Abstract:Flavonoids are a biodiverse family of dietary compounds that have antioxidant, anti-inflammatory, antiviral, and antibacterial cell protective profiles. They have received considerable attention as potential therapeutic agents in biomedicine and have been widely used in traditional complimentary medicine for generations. Such complimentary medical herbal formulations are extremely complex mixtures of many pharmacologically active compounds that provide a therapeutic outcome through a network pharmacological effects of considerable complexity. Methods are emerging to determine the active components used in complimentary medicine and their therapeutic targets and to decipher the complexities of how network pharmacology provides such therapeutic effects. The gut microbiome has important roles to play in the generation of bioactive flavonoid metabolites retaining or exceeding the antioxidative and anti-inflammatory properties of the intact flavonoid and, in some cases, new antitumor and antineurodegenerative bioactivities. Certain food items have been identified with high prebiotic profiles suggesting that neutraceutical supplementation may be beneficially employed to preserve a healthy population of bacterial symbiont species and minimize the establishment of harmful pathogenic organisms. Gut health is an important consideration effecting the overall health and wellbeing of linked organ systems. Bioconversion of dietary flavonoid components in the gut generates therapeutic metabolites that can also be transported by the vagus nerve and systemic circulation to brain cell populations to exert a beneficial effect. This is particularly important in a number of neurological disorders (autism, bipolar disorder, AD, PD) characterized by effects on moods, resulting in depression and anxiety, impaired motor function, and long-term cognitive decline. Native flavonoids have many beneficial properties in the alleviation of inflammation in tissues, however, concerns have been raised that therapeutic levels of flavonoids may not be achieved, thus allowing them to display optimal therapeutic effects. Dietary manipulation and vagal stimulation have both yielded beneficial responses in the treatment of autism spectrum disorders, depression, and anxiety, establishing the vagal nerve as a route of communication in the gut-brain axis with established roles in disease intervention. While a number of native flavonoids are beneficial in the treatment of neurological disorders and are known to penetrate the blood–brain barrier, microbiome-generated flavonoid metabolites (e.g., protocatechuic acid, urolithins, γ-valerolactones), which retain the antioxidant and anti-inflammatory potency of the native flavonoid in addition to bioactive properties that promote mitochondrial health and cerebrovascular microcapillary function, should also be considered as potential biotherapeutic agents. Studies are warranted to experimentally examine the efficacy of flavonoid metabolites directly, as they emerge as novel therapeutic options.

Targeting Gut-Brain Axis by Dietary Flavonoids Ameliorate Aging-Related Cognition Decline: Evidences and Mechanisms.

Dietary Flavonoids: Role in Preventing Neurodegenerative Diseases Caused by Brain Aging by Modulating the Gut Microbiota

Reader Response: Long-term Dietary Flavonoid Intake and Subjective Cognitive Decline in US Men and Women

Targeting NAD + Degradation: the Therapeutic Potential of Flavonoids for Alzheimer's Disease and Cognitive Frailty

Enhancing the Cognitive Effects of Flavonoids With Physical Activity: Is There a Case for the Gut Microbiome?

The neuromodulatory effects of flavonoids and gut Microbiota through the gut-brain axis

Role of BDNF Signaling in the Neuroprotective and Memory-enhancing Effects of Flavonoids in Alzheimer's Disease

Long-term Dietary Flavonoid Intake and Subjective Cognitive Decline in US Men and Women

Flavanols, mild cognitive impairment, and Alzheimer's dementia.

Flavonoids and Alzheimer's disease: reviewing the evidence for neuroprotective potential

Gut microbiota-derived short chain fatty acids act as mediators of the gut–brain axis targeting age-related neurodegenerative disorders: a narrative review

Flavonoids with Potential Anti-Amyloidogenic Effects As Therapeutic Drugs for Treating Alzheimer’s Disease

Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic Strategies Using Phytochemicals

Associations of Vegetable and Fruit Intake with Cognitive Function and Its Decline: Two Longitudinal Studies

The role of natural flavonoids on neuroinflammation as a therapeutic target for Alzheimer's disease: a narrative review

The Role of Natural Flavonoids on Neuroinflammation As a Therapeutic Target for Alzheimer’s Disease: a Narrative Review

A Narrative Review of the Effects of Citrus Peels and Extracts on Human Brain Health and Metabolism

Red Cabbage Anthocyanins Attenuate Cognitive Impairment by Attenuating Neuroinflammation and Regulating Gut Microbiota in Aging Mice.

The Potential of Flavonoids and Flavonoid Metabolites in the Treatment of Neurodegenerative Pathology in Disorders of Cognitive Decline

Protective effect of flavonoids on oxidative stress injury in Alzheimer's disease

Cognitive decline, dietary factors and gut-brain interactions